mhurhangee/ep-ind-claims huggingface dataset:
A method for attaching teat cups to milking animals standing on a rotary parlour, wherein the parlour comprises an annular rotary platform adapted to form a support surface for the animals, positioning means (19, 23) for arranging the animals in milking positions on the platform, a drive mechanism adapted to supply a rotational motion to the platform, and teat cup storing devices for holding parked teat cups (2, 2') in predetermined storing positions vertically above the platform, said teat cup storing devices are arranged in positions such that an animal standing in a milking position has a teat cup storing devices on each side and that the teat cup storing devices are arranged in positions such that the teat cups (2, 2'), which are to be attached to an animal standing in a milking position, are located in a storing position in front of a rear leg and behind a front leg of said animal and that each teat cup storing device is included in a cabinet like structure, and a milking robot arm having an extension between an inner end portion and an outer end portion, wherein the inner end portion is located at the side of the platform and the outer end portion comprises a gripping device for gripping and attaching teat cups (2, 2') to the teats of an animal standing in a milking position, characterised by the steps of moving the gripping device of the robot arm, via a space between the rear legs of the animal, to a gripping position above the platform in which gripping position it grips at least one teat cup in the storing device and moving the gripped teat cup (2, 2') to an attaching position under the udder of an animal standing in a milking position in which attaching position it attaches the teat cup (2, 2') to a teat of the animal.
Liquid-crystalline medium having a nematic phase and a dielectric anisotropy (Δε) of 0.5 or more characterized in that it has either - a dielectric constant perpendicular to the director (ε ⊥) in the range of 2 or more to 8 or less and at the same time a ratio of the dielectric constant perpendicular to the director (ε ⊥) to the dielectric anisotropy (Δε), i.e. (ε ⊥ / Δε) of 1.0 or more or - a dielectric constant perpendicular to the director (ε ⊥) of 8 or more and a dielectric anisotropy (Δε) of 26 or less and in that - it comprises one or more compounds having a high dielectric constant perpendicular to the director (ε ⊥) and a high average dielectric constant (ε av.), which are compounds of formula I, in which denotes or denotes or n denotes 0 or 1, R 11 and R 12 independently of each other denote alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, and R 11 alternatively denotes R 1 and R 12 alternatively denotes X 1, R 1 denotes alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably having 1 to 7 C atoms, alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl having 2 to 7 C atoms, and X 1 denotes F, Cl, fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy or fluorinated alkenyoxy. - a dielectric constant perpendicular to the director (ε ⊥) in the range of 2 or more to 8 or less and at the same time a ratio of the dielectric constant perpendicular to the director (ε ⊥) to the dielectric anisotropy (Δε), i.e. (ε ⊥ / Δε) of 1.0 or more or - a dielectric constant perpendicular to the director (ε ⊥) of 8 or more and a dielectric anisotropy (Δε) of 26 or less and in that - it comprises one or more compounds having a high dielectric constant perpendicular to the director (ε ⊥) and a high average dielectric constant (ε av.), which are compounds of formula I, in which denotes or denotes or n denotes 0 or 1, R 11 and R 12 independently of each other denote alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, and R 11 alternatively denotes R 1 and R 12 alternatively denotes X 1, R 1 denotes alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably having 1 to 7 C atoms, alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl having 2 to 7 C atoms, and X 1 denotes F, Cl, fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy or fluorinated alkenyoxy. n denotes 0 or 1, R 11 and R 12 independently of each other denote alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, and R 11 alternatively denotes R 1 and R 12 alternatively denotes X 1, R 1 denotes alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably having 1 to 7 C atoms, alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl having 2 to 7 C atoms, and X 1 denotes F, Cl, fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy or fluorinated alkenyoxy.
A mobile station apparatus which communicates with a base station apparatus, the mobile station apparatus being configured to: receive information about a number of antenna ports for a sounding reference signal, SRS, N p, and SRS parameters for transmitting the SRS; determine, for each antenna port p, a cyclic shift α(p) according to formulas and: α p = 2 πn CS, p SRS / 8; n CS, p SRS = n CS SRS + 8 p / N p mod 8; where n CS SRS is a value set by the SRS parameters; determine a sequence r (α(p)) u,v (n) according to formula: r α p u ⁢,v n = e j ⁢ α p n r o u, v n; where r O u,v (n) is a reference sequence; and transmit the SRS by using the sequence r (α(p)) u,v (n). receive information about a number of antenna ports for a sounding reference signal, SRS, N p, and SRS parameters for transmitting the SRS; determine, for each antenna port p, a cyclic shift α(p) according to formulas and: α p = 2 πn CS, p SRS / 8; n CS, p SRS = n CS SRS + 8 p / N p mod 8; where n CS SRS is a value set by the SRS parameters; determine a sequence r (α(p)) u,v (n) according to formula: r α p u ⁢,v n = e j ⁢ α p n r o u, v n; where r O u,v (n) is a reference sequence; and transmit the SRS by using the sequence r (α(p)) u,v (n).
A liquid pharmaceutical composition comprising: - 45 to 55 mg/ml adalimumab; - 5 to 14 mM sodium citrate/citric acid buffer system; - 190 to 210 mM trehalose; - 40 to 60 mM sodium chloride; - optionally 0.9 mg/mL to 1.1 mg/mL polysorbate 80; and - water (for injection); - wherein the composition: o has a pH between between 5.7 and 5.9; o is free of arginine or comprises arginine in a concentration of at most 0.001 mM; o is free of amino acids or comprises one or more amino acids in a (collective) concentration of at most 0.001 mM. o is free of surfactants with the optional exception of polysorbate 80 or comprises one or more of said surfactants (optionally excluding polysorbate 80) in a (collective) concentration of at most 0.0001 mM; and o is free of phosphate buffering agents or comprises a phosphate buffer system in a concentration of at most 0.001 mM. - 45 to 55 mg/ml adalimumab; - 5 to 14 mM sodium citrate/citric acid buffer system; - 190 to 210 mM trehalose; - 40 to 60 mM sodium chloride; - optionally 0.9 mg/mL to 1.1 mg/mL polysorbate 80; and - water (for injection); - wherein the composition: o has a pH between between 5.7 and 5.9; o is free of arginine or comprises arginine in a concentration of at most 0.001 mM; o is free of amino acids or comprises one or more amino acids in a (collective) concentration of at most 0.001 mM. o is free of surfactants with the optional exception of polysorbate 80 or comprises one or more of said surfactants (optionally excluding polysorbate 80) in a (collective) concentration of at most 0.0001 mM; and o is free of phosphate buffering agents or comprises a phosphate buffer system in a concentration of at most 0.001 mM. o has a pH between between 5.7 and 5.9; o is free of arginine or comprises arginine in a concentration of at most 0.001 mM; o is free of amino acids or comprises one or more amino acids in a (collective) concentration of at most 0.001 mM. o is free of surfactants with the optional exception of polysorbate 80 or comprises one or more of said surfactants (optionally excluding polysorbate 80) in a (collective) concentration of at most 0.0001 mM; and o is free of phosphate buffering agents or comprises a phosphate buffer system in a concentration of at most 0.001 mM.
An expression cassette comprising: (i) a nucleic acid molecule comprising a nucleotide sequence selected from: a) a nucleotide sequence comprising the sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence comprising the plant promoter sequences of the plasmids deposited as Patent Deposit No. NRRL B-50462; c) a nucleotide sequence comprising nucleotides 356 to 1710 of SEQ ID NO: 1; d) a nucleotide sequence comprising nucleotides 769 to 1710 of SEQ ID NO: 1; or e) a nucleotide sequence comprising nucleotides 1165 to 1710 of SEQ ID NO: 1; wherein said nucleotide sequence initiates transcription in a plant cell, and (ii) a heterologous nucleotide sequence of interest operably linked to the nucleic acid molecule. (i) a nucleic acid molecule comprising a nucleotide sequence selected from: a) a nucleotide sequence comprising the sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence comprising the plant promoter sequences of the plasmids deposited as Patent Deposit No. NRRL B-50462; c) a nucleotide sequence comprising nucleotides 356 to 1710 of SEQ ID NO: 1; d) a nucleotide sequence comprising nucleotides 769 to 1710 of SEQ ID NO: 1; or e) a nucleotide sequence comprising nucleotides 1165 to 1710 of SEQ ID NO: 1; wherein said nucleotide sequence initiates transcription in a plant cell, and a) a nucleotide sequence comprising the sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence comprising the plant promoter sequences of the plasmids deposited as Patent Deposit No. NRRL B-50462; c) a nucleotide sequence comprising nucleotides 356 to 1710 of SEQ ID NO: 1; d) a nucleotide sequence comprising nucleotides 769 to 1710 of SEQ ID NO: 1; or e) a nucleotide sequence comprising nucleotides 1165 to 1710 of SEQ ID NO: 1; (ii) a heterologous nucleotide sequence of interest operably linked to the nucleic acid molecule.
A particle-producing method comprising: discharging a liquid from discharge holes provided on a liquid-storing unit storing the liquid to make the liquid into droplets, the liquid containing a physiologically active substance and a polymer, wherein the physiologically active substance is a solid dispersion; and solidifying the droplets into a particle, wherein the physiologically active substance is in a state of fine particles in the particle, wherein a content of the physiologically active substance in the particle is 25% by mass or more based on the mass of the particle, wherein the particle has a volume average particle diameter (Dv) of 12 μm to 100 μm, and a particle size distribution (volume average particle diameter (Dv)/number average particle diameter (Dn)) of 1.00 to 1.50. discharging a liquid from discharge holes provided on a liquid-storing unit storing the liquid to make the liquid into droplets, the liquid containing a physiologically active substance and a polymer, wherein the physiologically active substance is a solid dispersion; and solidifying the droplets into a particle, wherein the physiologically active substance is in a state of fine particles in the particle, wherein a content of the physiologically active substance in the particle is 25% by mass or more based on the mass of the particle, wherein the particle has a volume average particle diameter (Dv) of 12 μm to 100 μm, and a particle size distribution (volume average particle diameter (Dv)/number average particle diameter (Dn)) of 1.00 to 1.50.
Apparatus for the respirating of patients, for anesthesia through inhalation and for the administering of therapeutic gases through inhalation, which apparatus is provided with means for the circulating in one direction in a line system of breathing gas, an anesthetic gas or a therapeutic gas, with means for varying the pressure in the line system in accordance with a certain respirating pattern, with means for measuring the flow of the gas and the composition of the gas, whilst the line system is provided with connecting means for the patient and with further supplies for the various components of the gas and with a line system part in which an absorber device is provided for the withdrawing of the carbon dioxide exhaled by the patient in the line system, whereby the line system further is provided with a by-pass line with closing means for completely or partly leading of the respiratory gas outside of the line system part with the absorber device, characterized in that a control unit is provided by means of which the operating of the closing means takes place in dependence on one or more measurements of the concentration of carbon dioxide in the respiratory gas in the line system, and wherein the line system is provided with a circulation blower.
A pneumatic tool comprising: a drive part configured to be driven by compressed air; a control valve configured to switch the presence or absence of operation of the drive part; an on-off valve part configured to switch the presence or absence of operation of the control valve; and a timer part configured to control the operation of the on-off valve part and switch the presence or absence of operation of the control valve after a lapse of a predetermined time, wherein the timer part comprises a timer piston configured to move in one direction and perform timekeeping, and a timer piston cylinder configured to support the timer piston such that the timer piston can slide, wherein the pneumatic tool comprises a throttle part configured to throttle the flow rate of air flowing into or flowing out from the timer piston cylinder, and an adjustment part (94, 95, 96) configured to adjust an operating time of the timer piston, characterized in that the timer part comprises a timer piston housing assembly in which a plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F) supporting the timer piston are fitted in an axial direction of the timer piston, and wherein, in the timer piston housing assembly, a flow path is formed between the plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F), and the plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F) are fitted via ribs having a crushing margin for aligning the positions of central axes of the plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F). a drive part configured to be driven by compressed air; a control valve configured to switch the presence or absence of operation of the drive part; an on-off valve part configured to switch the presence or absence of operation of the control valve; and a timer part configured to control the operation of the on-off valve part and switch the presence or absence of operation of the control valve after a lapse of a predetermined time, wherein the timer part comprises a timer piston configured to move in one direction and perform timekeeping, and a timer piston cylinder configured to support the timer piston such that the timer piston can slide, wherein the pneumatic tool comprises a throttle part configured to throttle the flow rate of air flowing into or flowing out from the timer piston cylinder, and an adjustment part (94, 95, 96) configured to adjust an operating time of the timer piston, characterized in that the timer part comprises a timer piston housing assembly in which a plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F) supporting the timer piston are fitted in an axial direction of the timer piston, and wherein, in the timer piston housing assembly, a flow path is formed between the plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F), and the plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F) are fitted via ribs having a crushing margin for aligning the positions of central axes of the plurality of timer piston housings (82A, 82B, 82C, 82D, 82E, 82F).
A multi-leaved core damping disk (90, 95) comprising: a first disk half having a first friction surface at a first axial end of the first disk half and a first non-friction surface at a second axial end of the first disk half; a second disk half having a second friction surface at a third axial end of the second disk half and a second non-friction surface at a fourth axial end of the second disk half, wherein the first friction surface is disposed at a fifth axial end of the multi-leaved core damping disk (90, 95) and the second friction surface is disposed at a sixth axial end of the multi-leaved core damping disk; and a multi-leaved core (210, 400, 500) disposed between, and axially aligned with, the first disk half and the second disk half; wherein the multi-leaved core (210, 400, 500) comprises a plurality of disk leaves, and characterized by the multi-leaved core (210, 400, 500) including a first disk leaf and a second disk leaf, and a cavity is disposed between the first disk leaf and the second disk leaf, and further wherein one or both of the first disk leaf and the second disk leaf include a circumferentially extending recess in contact with a spacer to form said cavity and wherein the first disk half and the second disk half are secured to the multi-leaved core via a fastner. a first disk half having a first friction surface at a first axial end of the first disk half and a first non-friction surface at a second axial end of the first disk half; a second disk half having a second friction surface at a third axial end of the second disk half and a second non-friction surface at a fourth axial end of the second disk half, wherein the first friction surface is disposed at a fifth axial end of the multi-leaved core damping disk (90, 95) and the second friction surface is disposed at a sixth axial end of the multi-leaved core damping disk; and a multi-leaved core (210, 400, 500) disposed between, and axially aligned with, the first disk half and the second disk half; wherein the multi-leaved core (210, 400, 500) comprises a plurality of disk leaves, and characterized by the multi-leaved core (210, 400, 500) including a first disk leaf and a second disk leaf, and a cavity is disposed between the first disk leaf and the second disk leaf, and further wherein one or both of the first disk leaf and the second disk leaf include a circumferentially extending recess in contact with a spacer to form said cavity and wherein the first disk half and the second disk half are secured to the multi-leaved core via a fastner.
An adhesive device for constructing segmented rotor blades comprising at least three prefabricated rotor blade parts, namely nose shell, middle part segment, and rear edge segment, exhibiting: a first accommodating region for receiving the prefabricated nose shell, a second accommodating region for receiving the prefabricated middle part segment and a third accommodating region for receiving the prefabricated rear edge segment, wherein the first accommodating region, the second accommodating region and the third accommodating region can be moved relative to each other such that, after the three prefabricated rotor blade parts (1, 2, 3) have been accommodated in the intended accommodating regions (11, 12, 13) in an open position of the adhesive device, these rotor blade parts (1, 2, 3) can be brought into direct or indirect contact with each other via predetermined adhesion regions (21, 22) and thus transferred to an adhesion position, wherein a second retaining structure for the second accommodating region is provided between a first retaining structure for the first accommodating region and a third retaining structure for the third accommodating region, characterized in that the first retaining structure with the first accommodating region and the nose shell as well as the third retaining structure with the third accommodating region and the rear edge segment can be moved toward the middle part segment received in the second accommodating region, while the second accommodating region with the middle part segment remains spatially fixed in place.
A railroad crossing frog with moving point, comprising: - a cradle assembly including an embedding part for a moving point, which has two lug end elements (35, 36) spaced apart from one another, - a moving point mounted in the cradle assembly while being embedded in the embedding part, the moving point including two rails (43, 44) comprising a core, a head and a shoe, and extending so as to converge toward the point end, the latter being made up of the end of one of the two rails (43, 44); - spacer parts inserted between the lug end elements (35, 36) and the moving point, and - fastening and wedging means that can be disassembled from the moving point in the embedding part, each spacer part being bearing, by an outer lateral face, on an inner face of the corresponding lug end element (35, 36), and by an inner lateral face, on an outer flank of the core of the corresponding rail (43, 44), the spacer parts having a shape adapted to cooperate by shape matching with a part of the outer profile of the respective rail (43, 44) of the moving point, and the spacer parts being fixed separately on the lug end elements (35, 36) by said separable fastening and wedging means, such that the vertical disassembly of the point from its embedding position with the spacer parts relative to the cradle assembly is possible, characterized in that said fastening and wedging means comprise, for each spacer part, at least one safety wedge fixed separately on a lug end element (35, 36), for example by screwing, bearing on an upper face of the spacer part, so as to limit the vertical travel of the point. - a cradle assembly including an embedding part for a moving point, which has two lug end elements (35, 36) spaced apart from one another, - a moving point mounted in the cradle assembly while being embedded in the embedding part, the moving point including two rails (43, 44) comprising a core, a head and a shoe, and extending so as to converge toward the point end, the latter being made up of the end of one of the two rails (43, 44); - spacer parts inserted between the lug end elements (35, 36) and the moving point, and - fastening and wedging means that can be disassembled from the moving point in the embedding part,
A method for treating a metal surface, in particular of a medical device, comprising the following steps: - providing a colloid dispersed system comprising first particles; - applying a first layer by a plasma electrolytic oxidation wherein the first particles are deposited on the surface; - applying a second layer, and wherein silver particles are provided as said first particles, and wherein said first or said second layer comprises a biodegradable material, or wherein the second is applied below the first layer and is a layer with a material which has a higher standard electrode potential as the material of the first layer. - providing a colloid dispersed system comprising first particles; - applying a first layer by a plasma electrolytic oxidation wherein the first particles are deposited on the surface; - applying a second layer, and wherein silver particles are provided as said first particles, and wherein said first or said second layer comprises a biodegradable material, or wherein the second is applied below the first layer and is a layer with a material which has a higher standard electrode potential as the material of the first layer.